Cochrane Abstracts
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles Edited (no change to conclusions), comment added to review
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles Edited (no change to conclusions), comment added to review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Recombinant Versus Urinary Gonadotrophin for Ovarian Stimulation in Assisted Reproductive Technology Cycles Edited (no Change to Conclusions), Comment Added to Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435517/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles_Edited__no_change_to_conclusions___comment_added_to_review. Accessed 04 July 2020.
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles Edited (no change to conclusions), comment added to review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435517/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles_Edited__no_change_to_conclusions___comment_added_to_review. Accessed July 4, 2020.
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles Edited (no change to conclusions), comment added to review. In Cochrane Abstracts Retrieved July 04, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/435517/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles_Edited__no_change_to_conclusions___comment_added_to_review
Recombinant Versus Urinary Gonadotrophin for Ovarian Stimulation in Assisted Reproductive Technology Cycles Edited (no Change to Conclusions), Comment Added to Review [Internet]. In: Cochrane Abstracts. [cited 2020 July 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435517/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles_Edited__no_change_to_conclusions___comment_added_to_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles Edited (no change to conclusions), comment added to review
ID - 435517
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435517/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles_Edited__no_change_to_conclusions___comment_added_to_review
DB - Evidence Central
DP - Unbound Medicine
ER -
